Furthermore, activity of psoriasis, which could be aligned with complicated IP activity [22], was markedly improved in response to anti-IL-17/23 biologics treatment, suggesting that DIIP is more likely than worsening of pre-existing IP. This evidence concerns the gene IL17A and psoriasis.